2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
47
Leukemia
28
Prostatic Neoplasms
21
Burkitt Lymphoma
17
Leukemia, Biphenotypic, Acute
15
Lymphoma
13
Leukemia, Myeloid, Acute
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Lymphoma, Large B-Cell, Diffuse
6
Recurrence
5
Lymphoma, Non-Hodgkin
5
Myelodysplastic Syndromes
4
Hodgkin Disease
4
Pituitary Neoplasms
3
Pancreatic Neoplasms
3
Neoplasms
3
Lymphoma, T-Cell
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, Large-Cell, Anaplastic
3
Lymphoma, B-Cell
3
Dendritic Cell Sarcoma, Interdigitating
3
Breast Neoplasms
3
Anemia, Refractory, with Excess of Blasts
3
Rhabdoid Tumor
2
Polycystic Ovary Syndrome
2
Obesity
2
Multiple Myeloma
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Leukemia, Myelomonocytic, Juvenile
2
Interventions
Doxorubicin
17
Echocardiography
14
Exercise
9
Cyclophosphamide
9
Trastuzumab
8
Dexrazoxane
8
Electrocardiography
7
Razoxane
6
Carvedilol
6
Vincristine
4
Radiotherapy
4
Filgrastim
4
Docetaxel
4
Methotrexate
3
Granulocyte Colony-Stimulating Factor
3
Etoposide
3
Cisplatin
3
Atorvastatin
3
salicylhydroxamic acid
2
sacubitril and valsartan sodium hydrate drug combination
2
empagliflozin
2
dapagliflozin
2
Tablets
2
Social Determinants of Health
2
Silymarin
2
Prednisone
2
Paclitaxel
2
Neoadjuvant Therapy
2
Magnetic Resonance Spectroscopy
2
Leucovorin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cardiotoxicity
×
Hydrocortisone
×
Clear all
NCT01230983
2013-06-06
T-Cell #4
Children's Oncology Group
Phase 3
Completed
573 enrolled